Genetic Square: the story of a company that is redefining genetics

Genetic Square, a startup that hopes to revolutionize genetic testing, has raised a $2.5 million Series B round.The company is a collaboration between Microsoft and the medical device company Gilead Sciences, which acquired a 10% stake in the company in March.The funding will enable the company to expand its product portfolio and to grow its […]


Continue.. Genetic Square: the story of a company that is redefining genetics